Epidemiological Study to Evaluate Adherence to Treatment in Bipolar Disorder: Adherence Study

AstraZeneca300 enrolled

Overview

The purpose of this study is to estimate adherence to treatment in bipolar patients, to characterize patients based on adherence degree and to describe the variables linked to poor adherence to treatment in real-life practice.

Study Type

OBSERVATIONAL

Enrollment

300

Conditions

Bipolar Disorder

Eligibility

Sex: ALLMin age: 18 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Patients diagnosed with bipolar disorder I or II DSM-IV * Patients treated with at least one oral antipsychotic * Subjects able to read and write Exclusion Criteria: * Patients participating in clinical trials

Locations (24)

Research Site

Las Palmas, Gran Canarias, Spain

Research Site

Calahorra, La Rioja, Spain

Outcomes

Primary Outcomes

Morisky-Green Scale

Time frame: Once, at the visit moment

Drug Attitude Inventory Scale (DAI-10)

Time frame: Once, at the visit moment

Secondary Outcomes

Clinical Global Impressions for Bipolar illness-modified (CGI-BP-M)

Time frame: Once, at the visit moment

Functioning Assessment Short Test (FAST)

Time frame: Once, at the visit moment

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.